Skip to Main content Skip to Navigation
Journal articles

ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences

Stéphanie Espiard 1 Ludivine Drougat 1 Rossella Libé 1, 2 Guillaume Assié 1, 2 Karine Perlemoine 1 Laurence Guignat 2 Gaelle Barrande 3 Françoise Brucker-Davis 4, 5 Françoise Doullay 6 Stéphanie Lopez 7 Emmanuel Sonnet 8 Florence Torremocha 9 Denis Pinsard 10 Nathalie Chabbert-Buffet 11 Marie-Laure Raffin-Sanson 12 Lionel Groussin 1, 2 Françoise Borson-Chazot 13, 14 Joël Coste 15, 16 Xavier Bertagna 2 Constantine A. Stratakis 17 Felix Beuschlein 18 Bruno Ragazzon 1 Jérôme Bertherat 1, 2 
Abstract : CONTEXT:Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause of primary adrenal Cushing's syndrome (CS). ARMC5 germline mutations have been identified recently in PBMAH.OBJECTIVE:To determine the prevalence of ARMC5 mutations and analyze genotype-phenotype correlation in a large cohort of unrelated PBMAH patients with subclinical or clinical CS.PATIENTS AND METHODS:ARMC5 was sequenced in 98 unrelated PBMAH index cases. PBMAH was identified by bilateral adrenal nodular enlargement on computed tomography scan. The effect on apoptosis of ARMC5 missense mutants was tested in H295R and HeLa cells. Clinical and hormonal data were collected including midnight and urinary free cortisol levels, ACTH, androgens, renin/aldosterone ratio, cortisol after overnight dexamethasone suppression test, cortisol and 17-hydroxyprogesterone after ACTH 1-24 stimulation and illegitimate receptor responses. Computed tomography and histological reports were analyzed.RESULTS:ARMC5-damaging mutations were identified in 24 patients (26%). The missense mutants and the p.F700del deletion were unable to induce apoptosis in both H295R and HeLa cell lines, unlike the wild-type gene. ARMC5-mutated patients showed an overt CS more frequently, compared to wild-type patients: lower ACTH, higher midnight plasma cortisol, urinary free cortisol, and cortisol after dexamethasone suppression test (P = .003, .019, .006, and <.001, respectively). Adrenals of patients with mutations were bigger and had a higher number of nodules (P = .001 and <.001, respectively).CONCLUSIONS:ARMC5 germline mutations are common in PBMAH. Index cases of mutation carriers show a more severe hypercortisolism and larger adrenals. ARMC5 genotyping may help to identify clinical forms of PBMAH better and may also allow earlier diagnosis of this disease.
Document type :
Journal articles
Complete list of metadata
Contributor : APEMAC UL Connect in order to contact the contributor
Submitted on : Tuesday, June 12, 2018 - 5:21:36 PM
Last modification on : Friday, September 30, 2022 - 4:20:05 PM

Links full text



Stéphanie Espiard, Ludivine Drougat, Rossella Libé, Guillaume Assié, Karine Perlemoine, et al.. ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences. Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2015, 100 (6), pp.E926-E935. ⟨10.1210/jc.2014-4204⟩. ⟨hal-01813998⟩



Record views